← Leaderboards
Jesse B Wolinsky
Fifth Base, Llc
$1,422,091
Attributed
$1,422,091
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $907.7K · FY2008–12$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$1,422,091 · 3
By mechanism
R44$1,000,371 · 1
R43$421,720 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsAnimal ModelPreventRecurrenceCommercializationIn VivoMalignant Neoplasm Of LungOperative Surgical ProceduresToxic EffectSafetyAnimalsChemotherapyBaseIn VitroImplantationInvestigationLeadEvaluationCharacteristicsAntineoplastic AgentsAdverse EffectsDrug DesignCancer PatientDisorder By Site
Grant awards (4)
Prevention of Tumor Recurrence Following Surgical Resection (Phase II)$92,710
R44 · FY2012 · CA · contact PI
Prevention of Tumor Recurrence Following Surgical Resection (Phase II)$907,661
R44 · FY2011 · CA · contact PI
Prevention of Tumor Recurrence Following Surgical Resection$255,800
R43 · FY2008 · CA · contact PI
Functional Vectors for Treatment of Mesothelioma$165,920
R43 · FY2008 · CA · contact PI